These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15744072)

  • 21. Penetration of micafungin into the burn eschar in patients with severe burns.
    Sasaki J; Yamanouchi S; Sato Y; Abe S; Shinozawa Y; Kishino S; Aikawa N; Hori S
    Eur J Drug Metab Pharmacokinet; 2014 Jun; 39(2):93-7. PubMed ID: 23771854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Optimal prophylactic dosage and disposition of micafungin in living donor liver recipients.
    Kishino S; Ohno K; Shimamura T; Furukawatodo H
    Clin Transplant; 2004 Dec; 18(6):676-80. PubMed ID: 15516243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and safety of micafungin as an empirical antifungal therapy for suspected fungal infection in neutropenic patients with hematological disorders.
    Yoshida M; Tamura K; Imamura M; Niitsu Y; Sasaki T; Urabe A; Ohyashiki K; Naoe T; Kanamaru A; Tanimoto M; Masaoka T
    Ann Hematol; 2012 Mar; 91(3):449-57. PubMed ID: 21894476
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of plasma exchange on pharmacokinetic disposition of micafungin.
    Konishi H; Fukushima K; Saotome T; Hamamoto T; Eguchi Y; Sudo M; Sumi M; Minouchi T; Iga I; Yamaji A
    Ther Apher Dial; 2010 Jun; 14(3):358-63. PubMed ID: 20609192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tissue distribution after intravenous dosing of micafungin, an antifungal drug, to rats.
    Niwa T; Yokota Y; Tokunaga A; Yamato Y; Kagayama A; Fujiwara T; Hatakeyama J; Anezaki M; Ohtsuka Y; Takagi A
    Biol Pharm Bull; 2004 Jul; 27(7):1154-6. PubMed ID: 15256761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case of Aspergillus empyema successfully treated with combination therapy of voriconazole and micafungin: excellent penetration of voriconazole and micafungin into pleural fluid.
    Matsuda T; Koreeda Y; Mataki H; Taira T; Noma S; Higashimoto I
    Intern Med; 2010; 49(12):1163-9. PubMed ID: 20558936
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful treatment of oesophageal candidiasis by micafungin: a novel systemic antifungal agent.
    Pettengell K; Mynhardt J; Kluyts T; Lau W; Facklam D; Buell D;
    Aliment Pharmacol Ther; 2004 Aug; 20(4):475-81. PubMed ID: 15298643
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combination therapy of micafungin and itraconazole for a case of pulmonary aspergillosis].
    Maruyama T; Takagi T; Yuda H
    Nihon Kokyuki Gakkai Zasshi; 2005 Feb; 43(2):94-8. PubMed ID: 15770940
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis.
    Pappas PG; Rotstein CM; Betts RF; Nucci M; Talwar D; De Waele JJ; Vazquez JA; Dupont BF; Horn DL; Ostrosky-Zeichner L; Reboli AC; Suh B; Digumarti R; Wu C; Kovanda LL; Arnold LJ; Buell DN
    Clin Infect Dis; 2007 Oct; 45(7):883-93. PubMed ID: 17806055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy in treatment of experimental pulmonary aspergillosis: synergistic interaction between an antifungal triazole and an echinocandin.
    Petraitis V; Petraitiene R; Sarafandi AA; Kelaher AM; Lyman CA; Casler HE; Sein T; Groll AH; Bacher J; Avila NA; Walsh TJ
    J Infect Dis; 2003 Jun; 187(12):1834-43. PubMed ID: 12792859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Invasive pulmonary aspergillosis with hematological malignancy caused by Aspergillus terreus and in vitro susceptibility of A. terreus isolate to micafungin.
    Tokimatsu I; Kushima H; Iwata A; Hashinaga K; Umeki K; Ohama M; Kohno K; Ishii H; Kishi K; Ogata M; Hiramatsu K; Saikawa T; Kadota J
    Intern Med; 2007; 46(11):775-9. PubMed ID: 17541234
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The pharmacokinetics and safety of micafungin, a novel echinocandin, in premature infants.
    Heresi GP; Gerstmann DR; Reed MD; van den Anker JN; Blumer JL; Kovanda L; Keirns JJ; Buell DN; Kearns GL
    Pediatr Infect Dis J; 2006 Dec; 25(12):1110-5. PubMed ID: 17133155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical effects of micafungin, a novel echinocandin antifungal agent, on systemic fungal infections in surgery, emergency, and intensive-care medicine: evaluation using the AKOTT algorithm.
    Aikawa N; Kusachi S; Oda S; Takesue Y; Tanaka H
    J Infect Chemother; 2009 Aug; 15(4):219-27. PubMed ID: 19688240
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of blood decrease on micafungin disposition in rats.
    Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Yamaji A
    Eur J Drug Metab Pharmacokinet; 2011 Mar; 36(1):35-9. PubMed ID: 21350921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced elimination clearance of micafungin in rats with cholestatic hyperbilirubinemia.
    Konishi H; Fukushima K; Sudo M; Sumi M; Minouchi T; Iga I; Shibata N; Takada K; Yamaji A
    Fundam Clin Pharmacol; 2010 Aug; 24(4):457-62. PubMed ID: 19845766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin.
    Olson JA; Adler-Moore JP; Smith PJ; Proffitt RT
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4895-902. PubMed ID: 16304150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of micafungin versus extensive azoles in the prevention and treatment of invasive fungal infections for neutropenia patients with hematological malignancies: A meta-analysis of randomized controlled trials.
    Lee CH; Lin JC; Ho CL; Sun M; Yen WT; Lin C
    PLoS One; 2017; 12(7):e0180050. PubMed ID: 28700646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combination antifungal therapy of murine aspergillosis: liposomal amphotericin B and micafungin.
    Graybill JR; Bocanegra R; Gonzalez GM; Najvar LK
    J Antimicrob Chemother; 2003 Oct; 52(4):656-62. PubMed ID: 12972452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, parallel-group, dose-response study of micafungin compared with fluconazole for the treatment of esophageal candidiasis in HIV-positive patients.
    de Wet N; Llanos-Cuentas A; Suleiman J; Baraldi E; Krantz EF; Della Negra M; Diekmann-Berndt H
    Clin Infect Dis; 2004 Sep; 39(6):842-9. PubMed ID: 15472817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concomitant cyclosporine and micafungin pharmacokinetics in healthy volunteers.
    Hebert MF; Townsend RW; Austin S; Balan G; Blough DK; Buell D; Keirns J; Bekersky I
    J Clin Pharmacol; 2005 Aug; 45(8):954-60. PubMed ID: 16027407
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.